RSS Feeds
Search

Press releases

Press releases

Displaying 1..1 of 1 - per page
Order by
LAY LINE GENOMICS (LLG) grants a non-exclusive license to LUNDBECK for its AD11 transgenic anti-NGF mouse
LAY LINE GENOMICS (LLG) grants a non-exclusive license to LUNDBECK for its AD11 transgenic anti-NGF mouse More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Clinical Trial Recruitment in Central Nervous System Disorders - Highest Number of Patients were Recruited for Clinical Trials in Schizophrenia
Sep 2011 - 97 pages - $3,500
Early Stage Drug Discovery in Disease Segments - Innovation Focuses on Stem Cell Therapies and Gene Therapies
Feb 2011 - 209 pages - $3,500
Other Central Nervous System Disorders Global Clinical Trials Review, Q1, 2011
Feb 2011 - 75 pages - $1,000
Deals and alliances in central nervous system diseases
Jun 2006 - 1068 pages - $2,495
Will 2011 Spell a Brighter Year for the Pharmaceutical Companies?
Mar 2011 - 6 pages - $500
Company Financials: Acadia Pharmaceuticals Inc.
Jan 2010 - $75
Suven Life Sciences Ltd. (530239) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Mar 2011 - 48 pages - $250
Emerging Technologies: Stem cells
Nov 2011 - 61 pages - $3,800
Sleep Disorders - Pipeline Review, Q3 2011
Jul 2011 - 136 pages - $500
Biomarkers: Technological and Commercial Outlook 2011-2021 - discovering the pharma and diagnostics opportunities
Jun 2011 - 132 pages - $2,350
More Related Market Research Reports >>>

Your selection

Industry sector
Drug discovery del
Therapeutic target
Central Nervous System del
Neurodegenerative disorders del
Year
2004 del

Browse By

Industry sector
Bioinformatics
Combinatorial biology
Combinatorial chemistry
Drug research platforms
Genomics
High throughput screening
Proteomics
Therapeutic target
Alzheimer's disease
Amyotrophic Lateral Sclerosis (Lou Gehri
Creutzfeldt-Jakob disease
Dementia
Multiple sclerosis
Parkinson's disease

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us